TANG Lihong, PAN Lingyi, QIU Jianyin, FAN Qing, PAN Guihua
Download PDF
(
)
Knowledge map
 
Save
Objective: To investigate the clinical efficacy of group body psychotherapy (GBPT) combined with routine medication treatment in the treatment of major depression.
Methods: From July 2017 to June 2019, 60 inpatients with moderate to severe depression in Shanghai Mental Health Center were selected and randomly assigned to the experimental group and control group, with 30 patients in each group. The patients in the control group received routine medication treatment, and the patients in the experimental group received GBPT on top of the basis. All the patients completed the 4-week intervention. The Hamilton Rating Scale for Depression (HAMD-17) score, Hamilton Anxiety Scale (HAMA) score, Pittsburgh Sleep Quality Index (PSQI) score, and the short-form McGill Pain Questionnaire (SF-MPQ) score of the patients in these two groups were compared at baseline, 4 weeks, and 8 weeks, respectively.
Results: The results of two-way repeated measures analysis of variance indicated that, compared with the control group, the combined intervention of GBPT could significantly reduce the HAMD-17 score (F=6.97, p<0.001) and improve the PSQI score (F=17.54, p<0.001), and had an interaction with the treatment time (F=12.09 and F=22.79, respectively; p<0.001). Although, compared with the control group, the combined treatment of GBPT for the improvement of somatic pain was not statistically significant (F=3.65, p=0.06), there was an interaction between the group and treatment time (F=11.84, p<0.001), indicating that the combined intervention of GBPT can improve patients’ somatic pain more rapidly.
Conclusions: Compared with the routine treatment, the combined treatment of GBPT with routine treatment could significantly reduce the depressive symptoms in patients and may have better clinical implications.